Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study compared a four-drug regimen (POLYCHEM) to standard diabetes care (SDC) in newly diagnosed type 2 diabetes patients, finding no significant difference in diabetes remission but a notable improvement in hyperglycemia regression with POLYCHEM.
The study examined the effects of finerenone on urinary albumin-to-creatinine ratio in adults with type 1 diabetes and chronic kidney disease, showing a significant reduction in UACR compared to placebo.
This study investigated the effects of progressive resistance training combined with vitamin D supplementation on glycemic control in elderly women with type 2 diabetes, finding significant improvements in several metabolic markers.
The study evaluated SiPore21's effects on glycaemic control and metabolic health in adults with prediabetes or early type 2 diabetes, finding significant improvements in several health markers.
This study evaluated the impact of remote nurse-led patient education on glycemic control in individuals with type 2 diabetes, finding significant improvements in various metabolic markers.
This study compared the efficacy of modified-release gliclazide and basal insulin in managing Type 2 diabetes. Both interventions significantly reduced HbA1c, fasting blood glucose, and postprandial blood glucose levels.
This study evaluated the impact of integrated self-management interventions on periodontal health and metabolic control in adults with type 2 diabetes, finding significant improvements in several health metrics.
The ONWARDS 10 trial evaluated the switch from daily basal insulin to once-weekly insulin icodec, finding improvements in HbA1c and time in range compared to glargine U100.
This study evaluated the efficacy and safety of adding a GLP-1 receptor agonist and SGLT2 inhibitor to insulin therapy in Type 1 Diabetes, finding significant improvements in HbA1c and quality of life.
This pilot randomized controlled trial evaluated the efficacy of the PROTEIN mobile app for glucose management in adults with prediabetes or type 2 diabetes, finding an increase in time in range.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
